BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 10805102)

  • 21. Enhanced apoptosis in pilocytic astrocytoma: a comparative study of apoptosis and proliferation in astrocytic tumors.
    Nakamizo A; Inamura T; Ikezaki K; Yoshimoto K; Inoha S; Mizoguchi M; Amano T; Fukui M
    J Neurooncol; 2002 Apr; 57(2):105-14. PubMed ID: 12125970
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinicopathological features, MIB-1 labeling index and apoptotic index in recurrent astrocytic tumors.
    Ralte AM; Sharma MC; Karak AK; Mehta VS; Sarkar C
    Pathol Oncol Res; 2001; 7(4):267-78. PubMed ID: 11882906
    [TBL] [Abstract][Full Text] [Related]  

  • 23. p53 protein alterations in adult astrocytic tumors and oligodendrogliomas.
    Nayak A; Ralte AM; Sharma MC; Singh VP; Mahapatra AK; Mehta VS; Sarkar C
    Neurol India; 2004 Jun; 52(2):228-32. PubMed ID: 15269478
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aberrant localization of the neuronal class III beta-tubulin in astrocytomas.
    Katsetos CD; Del Valle L; Geddes JF; Assimakopoulou M; Legido A; Boyd JC; Balin B; Parikh NA; Maraziotis T; de Chadarevian JP; Varakis JN; Matsas R; Spano A; Frankfurter A; Herman MM; Khalili K
    Arch Pathol Lab Med; 2001 May; 125(5):613-24. PubMed ID: 11300931
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative evaluation of p53-protein expression and the PCNA and Ki-67 proliferating cell indices in human astrocytomas.
    Kordek R; Biernat W; Debiec-Rychter M; Alwasiak J; Liberski PP
    Pathol Res Pract; 1996 Mar; 192(3):205-9. PubMed ID: 8739466
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Study of the MIB-1 labeling index as a predictor of tumor progression in pilocytic astrocytomas in children and adolescents.
    Bowers DC; Gargan L; Kapur P; Reisch JS; Mulne AF; Shapiro KN; Elterman RD; Winick NJ; Margraf LR
    J Clin Oncol; 2003 Aug; 21(15):2968-73. PubMed ID: 12885817
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlation between MIB-1 staining indices and recurrence in low-grade astrocytomas.
    Hoshi M; Yoshida K; Shimazaki K; Sasaki H; Otani M; Kawase T
    Brain Tumor Pathol; 1997; 14(1):47-51. PubMed ID: 9384802
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diversity of glial cell components in pilocytic astrocytoma.
    Tanaka Y; Sasaki A; Ishiuchi S; Nakazato Y
    Neuropathology; 2008 Aug; 28(4):399-407. PubMed ID: 18312545
    [TBL] [Abstract][Full Text] [Related]  

  • 29. J1-31 protein expression in astrocytes and astrocytomas.
    Shuangshoti S; Thorner PS; Ruangvejvorachai P; Saha B; Groshen S; Taylor CR; Malhotra S; Imam SA
    Neuropathology; 2009 Oct; 29(5):521-7. PubMed ID: 19019178
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Image cytometric measurement of nuclear proliferation markers (MIB-1, PCNA) in astrocytomas. Prognostic significance.
    Kirkegaard LJ; DeRose PB; Yao B; Cohen C
    Am J Clin Pathol; 1998 Jan; 109(1):69-74. PubMed ID: 9426520
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of proliferation and apoptosis in brain gliomas: prognostic and clinical value.
    Heesters MA; Koudstaal J; Go KG; Molenaar WM
    J Neurooncol; 1999; 44(3):255-66. PubMed ID: 10720205
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aggressive Low-Grade Optic Nerve Glioma in Adults.
    Bilgin G; Al-Obailan M; Bonelli L; Glasgow BJ; Vinters HV; Arnold AC
    Neuroophthalmology; 2014; 38(6):297-309. PubMed ID: 27928317
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The clinical value of Ki-67/MIB-1 labeling index in human astrocytomas.
    Johannessen AL; Torp SH
    Pathol Oncol Res; 2006; 12(3):143-7. PubMed ID: 16998593
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mutations and immunohistochemistry of p53 and proliferation markers in astrocytic tumors of childhood.
    Schiffer D; Cavalla P; Di Sapio A; Giordana MT; Mauro A
    Childs Nerv Syst; 1995 Sep; 11(9):517-22. PubMed ID: 8529218
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinicopathological features and global genomic copy number alterations of pilomyxoid astrocytoma in the hypothalamus/optic pathway: comparative analysis with pilocytic astrocytoma using array-based comparative genomic hybridization.
    Jeon YK; Cheon JE; Kim SK; Wang KC; Cho BK; Park SH
    Mod Pathol; 2008 Nov; 21(11):1345-56. PubMed ID: 18622384
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of morphology, MIB-1, p53 and MGMT on outcome in pilocytic astrocytomas.
    Horbinski C; Hamilton RL; Lovell C; Burnham J; Pollack IF
    Brain Pathol; 2010 May; 20(3):581-8. PubMed ID: 19832838
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of immunohistochemistry in predicting behavior of astrocytic tumors.
    Ambroise MM; Khosla C; Ghosh M; Mallikarjuna VS; Annapurneswari S
    Asian Pac J Cancer Prev; 2010; 11(4):1079-84. PubMed ID: 21133628
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proliferative Index in Pediatric Pilocytic Astrocytoma by Region of Origin and Prediction of Clinical Behavior.
    Tu A; Robison A; Melamed E; Buchanan I; Hariri O; Babu H; Szymanski L; Krieger M
    Pediatr Neurosurg; 2018; 53(6):395-400. PubMed ID: 30428478
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinicopathologic study of retinoblastoma including MIB-1, p53, and CD99 immunohistochemistry.
    Schwimer CJ; Prayson RA
    Ann Diagn Pathol; 2001 Jun; 5(3):148-54. PubMed ID: 11436168
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinicopathological correlation of cell proliferation, apoptosis and p53 in cerebellar pilocytic astrocytomas.
    Haapasalo H; Sallinen S; Sallinen P; Helén P; Jääskeläinen J; Salmi TT; Paetau A; Paljärvi L; Visakorpi T; Kalimo H
    Neuropathol Appl Neurobiol; 1999 Apr; 25(2):134-42. PubMed ID: 10216001
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.